SeouLinBioscience Co (XKRX:038070) Ending Cash Position : ₩8,949 Mil (As of Dec. 2024)

View and export this data going back to 2005. Start your Free Trial

What is SeouLinBioscience Co Ending Cash Position?

SeouLinBioscience Co's Ending Cash Position for the quarter that ended in Dec. 2024 was ₩8,949 Mil.

SeouLinBioscience Co's quarterly Ending Cash Position declined from Jun. 2024 (₩11,113 Mil) to Sep. 2024 (₩8,111 Mil) but then increased from Sep. 2024 (₩8,111 Mil) to Dec. 2024 (₩8,949 Mil).

SeouLinBioscience Co's annual Ending Cash Position increased from Dec. 2022 (₩8,999 Mil) to Dec. 2023 (₩14,602 Mil) but then declined from Dec. 2023 (₩14,602 Mil) to Dec. 2024 (₩8,949 Mil).

SeouLinBioscience Co Ending Cash Position Historical Data

The historical data trend for SeouLinBioscience Co's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SeouLinBioscience Co Ending Cash Position Chart

SeouLinBioscience Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Ending Cash Position

Get a 7-Day Free Trial

8,498.28

14,972.91

8,998.83

14,601.83

8,949.15

SeouLinBioscience Co Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Ending Cash Position	Get a 7-Day Free Trial															14,601.83	13,745.92	11,112.84	8,111.46	8,949.15

SeouLinBioscience Co Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

SeouLinBioscience Co's Ending Cash Position for the fiscal year that ended in Dec. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	14601.832	+	-5652.682
	=	8,949

SeouLinBioscience Co's Ending Cash Position for the quarter that ended in Dec. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	8111.462	+	837.688
	=	8,949

SeouLinBioscience Co Ending Cash Position Related Terms

Thank you for viewing the detailed overview of SeouLinBioscience Co's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

SeouLinBioscience Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » SeouLinBioscience Co Ltd (XKRX:038070) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

N/A

Address

4F, A-dong, Korea Bio Park, 694-1, Sampyeong-dong, Bundang-gu, Seongnam-si, Gyeonggi-do, KOR, 463-400

Website

http://www.seoulin.co.kr

SeouLinBioscience Co Ltd is a South Korean company operating in biotechnology industry. The company focuses on bio research and production, manufacturing, diagnostics, and healthcare.

SeouLinBioscience Co Headlines

No Headlines